About this Research Topic
Skeletal muscle and cardiovascular diseases continue to pose significant challenges to public health, affecting a wide range of population groups. While conventional treatments have provided some relief, the complexity of these diseases necessitates more progressive therapeutic approaches. The emergence of cellular and gene therapies offers groundbreaking potential in combating these conditions. Over the past few years, the approval of several gene and cell therapies by regulatory bodies marks a crucial milestone in medical treatment, encouraging new possibilities for patient care. These advances not only demonstrate a significant shift towards innovative therapeutic strategies but also highlight the growing acceptance of these therapies in enhancing outcomes for skeletal muscle and cardiovascular diseases.
This Research Topic aims to provide insight on the latest advancements in gene and cell therapy for treating skeletal muscle and cardiovascular diseases, covering research from basic science to clinical applications. We invite contributors to delve into expansive and crucial topics including:
-Innovative vector configurations designed specifically for muscle and regenerative treatments;
-Cutting-edge gene editing techniques targeting muscle cells and cardiac lineage;
-Approaches to reduce fibrosis and enhance angio-vasculogenesis using gene or cell therapies;
-Utilizing skeletal and cardiac muscle stem cells for therapeutic purposes;
-Recent developments in both ex vivo and in vivo gene therapy tactics for muscle and cardiovascular conditions;
-New methods for promoting tissue regeneration using gene and cell therapy techniques;
-Tissue-engineering strategies for the repair of skeletal or heart tissues.
This inclusive discussion aims to link novel research with practical applications, opening avenues for significant health improvements in affected populations.
We welcome submissions, though not limited, from the following article types: Original Research Articles, Reviews, Mini Reviews, and Opinion.
This Research Topic aims to provide insight on the latest advancements in gene and cell therapy for treating skeletal muscle and cardiovascular diseases, covering research from basic science to clinical applications. We invite contributors to delve into expansive and crucial topics including:
-Innovative vector configurations designed specifically for muscle and regenerative treatments;
-Cutting-edge gene editing techniques targeting muscle cells and cardiac lineage;
-Approaches to reduce fibrosis and enhance angio-vasculogenesis using gene or cell therapies;
-Utilizing skeletal and cardiac muscle stem cells for therapeutic purposes;
-Recent developments in both ex vivo and in vivo gene therapy tactics for muscle and cardiovascular conditions;
-New methods for promoting tissue regeneration using gene and cell therapy techniques;
-Tissue-engineering strategies for the repair of skeletal or heart tissues.
This inclusive discussion aims to link novel research with practical applications, opening avenues for significant health improvements in affected populations.
We welcome submissions, though not limited, from the following article types: Original Research Articles, Reviews, Mini Reviews, and Opinion.
Keywords: Gene Therapy, Skeletal muscle, Cardiovascular diseases, Cell therapy, Regenerative Medicine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
